Interim Details from United kingdom Com-COV study suggest bigger reactogenicity but continue being inconclusive
The Oxford-led Phase II Com-COV demo is investigating immune responses in people who have been
The Oxford-led Phase II Com-COV demo is investigating immune responses in people who have been